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Fear reinstatement is one of several paradigms designed to measure fear return following 
extinction, as a laboratory model for the relapse of Posttraumatic Stress Disorder (PTSD) 
symptoms. Sleep is a key factor in emotional memory consolidation, and here we examined 
the relationship between sleep quality and fear reinstatement in PTSD, relative to trauma-
exposed and non-exposed controls. The Pittsburgh Sleep Quality Index (PSQI) was used as a 
subjective measure of sleep quality, and skin conductance responses (SCR) and 
unconditioned stimulus (US)-expectancy ratings were used to index threat responses during a 
differential fear conditioning, extinction, and reinstatement paradigm. There were no 
significant between-group differences in the reinstatement of conditioned responding. Sleep 
disturbance and sleep onset latency were significant moderators between reinstatement of 
fear and PTSD symptom severity, such that there was a positive relationship between PTSD 
symptoms and fear reinstatement for higher levels – but not lower levels – of sleep 
disturbance and sleep onset latency. To our knowledge, this is the first study to investigate 
PTSD-specific reinstatement patterns and sleep as a boundary condition of reinstatement. 
Future research using polysomnographic measures of sleep-wave architecture may further 
clarify the relationship between fear reinstatement and sleep quality in clinical samples with 
PTSD relative to controls. 
 





A key biological model of Posttraumatic Stress Disorder (PTSD) is that fear-related 
symptoms are maintained, in part, due to impaired extinction of fear responses to benign 
stimuli that were conditioned with fear during the trauma (Mineka & Oehlberg, 2008; Pitman 
et al., 2012; Zuj, Palmer, Lommen, & Felmingham, 2016). Recently, the return of fear has 
been gaining attention as a laboratory model for the relapse of fear-related symptoms 
(Scheveneels, Boddez, Vervliet, & Hermans, 2016). Fear reinstatement refers to the return of 
fear following unsignalled encounters with an aversive stimulus (e.g., an electric shock; 
Dirikx, Hermans, Vansteenwegen, Baeyens, & Eelen, 2004), and is considered an 
experimental analogue for the return of fearful symptoms after re-exposure to a trauma 
reminder or spontaneous panic attacks (Haaker, Golkar, Hermans, & Lonsdorf, 2014; 
Scheveneels et al., 2016). Currently, our understanding of the moderators of fear 
reinstatement is limited, and more research is needed to understand the boundary conditions 
by which fear returns following unsignalled encounters with the unconditioned stimulus (US; 
Haaker et al., 2014). Due to the strong influence of sleep on emotional memory consolidation 
(e.g., Stickgold, 2005) and fear extinction memory (Pace-Schott, Germain, & Milad, 2015a, 
2015b), we hypothesized that the association between fear reinstatement and PTSD 
symptoms would vary depending on sleep quality. 
Fear reinstatement refers to a series of unsignalled presentations of the US following 
successful extinction learning, resulting in a temporary return of fear. This event is argued to 
temporarily disrupt the memory for extinction, and ‘reinstate’ the dormant conditioned fear 
association (Hermans et al., 2005). These unsignalled US presentations typically result in a 
temporary return of fear to the previously reinforced conditioned stimulus (termed the CS+), 
as measured by US-expectancy ratings and fear ratings (Dirikx, Hermans, Vansteenwegen, 
Baeyens, & Eelen, 2007; Dirikx, Vansteenwegen, Eelen, & Hermans, 2009), skin 
 4 
conductance response (Kull, Muller, Blechert, Wilhelm, & Michael, 2012), and fear-
potentiated startle (Norrholm et al., 2006). Further, fear reinstatement can also be non-
differential, with a brief increase in fearful responding to the safety signal (i.e., the CS-) as 
well as the CS+ (Dirikx et al., 2009; Kull et al., 2012). Fear reinstatement has been studied 
extensively in rodents (for a review, see Haaker et al., 2014), and boundary conditions of the 
return of fear following reinstatement in humans are only recently being investigated. 
However to our knowledge reinstatement has not yet been investigated in individuals with 
PTSD. 
 Sleep disturbances are considered a hallmark feature of PTSD (Germain, 2013) and 
have been shown to contribute to the longitudinal development of PTSD symptoms (Bryant, 
Creamer, O'Donnell, Silove, & McFarlane, 2010; van Liempt, van Zuiden, Westenberg, 
Super, & Vermetten, 2013). Sleep quality is considered essential in the consolidation and 
accurate recall of emotional memories (Stickgold, 2005), including the consolidation and 
memory for fear extinction (Pace-Schott et al., 2015a, 2015b). Recent research has found that 
rapid eye movement (REM) sleep amount is negatively correlated with SCR amplitude 
during fear extinction, suggesting that increased REM sleep is associated with greater fear 
extinction (Spoormaker, Gvozdanovic, Samann, & Czisch, 2014). Further research has also 
shown that a full night of sleep can enhance the generalization of extinction memories to 
similar unextinguished stimuli, compared to 12 hours of wakefulness throughout the day 
(Pace-Schott et al., 2009). Similarly, increased homeostatic sleep pressure, or the increased 
need for sleep throughout the day, can lead to poorer fear extinction learning in healthy men 
(Pace-Schott et al., 2013; Pace-Schott et al., 2014), and this relationship is stronger in PTSD 
(Zuj, Palmer, Hsu, et al., 2016). As far as we are aware, no research has looked at sleep 
quality as a possible moderator of the return of fear following reinstatement in healthy or 
clinical samples. 
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Sleep quality is a crucial factor in emotional memory consolidation (Diekelmann & 
Born, 2010; Stickgold, 2005), and we argue that sleep quality may act as a significant 
boundary condition of fear reinstatement. To our knowledge, the reinstatement of a 
conditioned fear has not yet been investigated in participants with PTSD, trauma-exposure 
without PTSD, and non-trauma-exposed healthy controls. For this reason, we did not 
hypothesize PTSD-specific reinstatement effects, but we did hypothesize that poor subjective 
sleep quality would be a significant moderator between the return of fear and PTSD 
symptoms. Specifically, we predicted that the association between fear return and PTSD 




Research participants were recruited to examine various moderators between 
processes of fear extinction learning and PTSD symptoms. As such, findings from this 
sample have been published previously examining hours-since-waking, cortisol reactivity, 
salivary α-amylase, and negative appraisals as potential moderators between fear extinction 
and PTSD symptoms (Zuj, Palmer, Gray, et al., 2017; Zuj, Palmer, Hsu, et al., 2016; Zuj, 
Palmer, Malhi, Bryant, & Felmingham, 2017, 2018). This paper makes a significant advance 
over previous published research from this sample, being the first to report on the findings of 
reinstatement and the relationship between reinstatement and sleep quality in PTSD. There 
were 74 participants aged 18-63 (31 males, 43 females). Participants completed the PTSD 
Checklist-Civilian version for DSM-IV (PCL-C, described below; Weathers, Litz, Huska, & 
Keane, 1994) to assess for the presence and severity of PTSD symptoms. The PCL-C for 
DSM-IV was used as diagnostic instruments for the DSM-5 were not available at the time of 
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testing. Participants reported previous trauma exposure by self-report with the Traumatic 
Events Questionnaire (TEQ; Vrana & Lauterbach, 1994). 
Responses on the PCL-C and TEQ determined allocation to one of three groups, high 
posttraumatic stress disorder symptoms (PTSD; n = 20), trauma-exposed controls (TC; n = 
29), and non-trauma-exposed controls (NTC; n = 25). Participants were allocated to the 
PTSD group if they reported experiencing one or more Criterion A stressors on the TEQ, and 
displayed at least one intrusive memory symptom, three avoidance symptoms, and two 
hyperarousal symptoms, according to the diagnostic criteria for DSM-IV. Mean years since 
trauma was 10.7 years (SD = 13 years) for the PTSD group, and 8.1 years (SD = 7.9 years) 
for the TC group. All reported traumatic events included combat in a war (7%), a life-
threatening accident (25.7%), fire, flood, or other life-threatening disaster (36.6%), witness 
injury or death (45.1%), seriously attacked, assaulted or molested (25.4%), threatened with a 
weapon, held captive or kidnapped (15.5%), tortured or the victim of terrorism (2.8%), 
experienced an extremely stressful or upsetting event (73.2%), and/or suffered a great shock 
because an event happened to somebody close (40.8%). Participants were allocated to the 
NTC group if they reported no experience of a Criterion A stressor.  
Exclusion was based on the use of psychoactive medication to prevent confounds on 
sleep behaviour and psychophysiological arousal, and on neurological history, psychosis, and 
bipolar. This was done with the use of a self-report medical screening questionnaire rather 
than clinical interview, as the researchers were not clinicians. Participants were also 
requested to abstain from caffeinated beverages on the day of testing. Due to the frequent 
comorbidity between PTSD and depression, depression was applied as a covariate in relevant 
analyses, rather than as a basis for exclusion from participation. The University of Tasmania 
Social Sciences ethics committee approved the study protocol, and all participants provided 




PTSD-Checklist Civilian version (PCL-C). The PCL-C is a self-report questionnaire 
with 17 items that correspond with the diagnostic criteria of the DSM-IV (Weathers et al., 
1994). Responses on the PCL-C are made on a five-point scale from 1 (“Not at all”) to 5 
(“Extremely”). Scores of 3 or higher are considered to be significant symptoms, contributing 
to the primary symptoms of intrusive memories, avoidance behaviors, and hyperarousal. All 
participants in the PTSD group had a PCL-C total score of at least 38. The minimum 
recommended cutoff for screening individuals in primary care settings is at least 30 (National 
Center for Posttraumatic Stress Disorder, n.d.). Participants were allocated to the TC group if 
they reported experience of one or more Criterion A stressors but did not meet the minimum 
recommended PCL-C cutoff of 30. Hence, the TC group showed a maximum PCL-C total 
score of 29. One participant in the TC group met potential criteria for sub-syndromal PTSD 
(as used by Shelby, Golden-Kreutz, & Andersen, 2008), with three hyperarousal symptoms. 
Omitting this participant had no effect on the statistical significance or direction of effects, 
and was retained in all analyses. The PCL-C for DSM-IV has excellent psychometric 
properties (Wilkins, Lang, & Norman, 2011). 
 
Pittsburgh Sleep Quality Index (PSQI). The PSQI is a 19 item questionnaire assessing 
subjective sleep quality over the past month (Buysse, Reynolds, Monk, Berman, & Kupfer, 
1989). Scores on the PSQI are used to calculate a global score ranging from 0-21 and seven 
equally weighted subscales with scores ranging from 0-3 (with higher scores indicating 
poorer sleep quality). The seven subscales are as follows: sleep disturbance, sleep duration, 
daytime dysfunction, habitual sleep efficiency, sleep latency, use of sleep medications, and 
subjective sleep quality. According to Buysse et al. (1989), global scores ≤ 5 indicate normal 
 8 
sleep, 6-10 indicate moderately impaired sleep, and scores ≥ 11 indicate severely impaired 
sleep. The PSQI is a widely used measure in clinical sleep research, and shows strong 
psychometric properties (Buysse et al., 1989; Mollayeva et al., 2016). 
 
2.3. Fear conditioning, extinction and reinstatement task 
The present study used a standardized fear conditioning and extinction task described 
previously (Zuj, Palmer, Gray, et al., 2017; Zuj, Palmer, Hsu, et al., 2016; Zuj, Palmer, 
Malhi, et al., 2017). The unconditioned stimulus (US) was a 500ms mild electric shock set to 
a level considered “highly annoying, but not painful” by each participant prior to beginning 
the task, and delivered to the first interosseous muscle of the dominant hand. Conditioned 
stimuli (CS) were red and blue circles presented on a white computer screen for 12s, with an 
inter-trial interval ranging from 12-21s. CS presentation occurred in a pseudo-random order, 
with no more than two consecutive trials of each stimulus. CS presentation, frequency and 
timings were based off the standardized conditioning and extinction paradigm by Orr et al. 
(2000). Participants first completed a habituation phase, consisting of four presentations of 
each of the two CS types, with eight trials in total. During acquisition, participants received 
five presentations of each CS type, with one CS being reinforced by the US immediately 
following CS offset on all trials (CS+). That is, the current study used a 100% reinforcement 
schedule during the acquisition phase (Orr et al., 2000). Following acquisition, participants 
completed the early and late extinction phases, which were separated by a small break of no 
more than 1min (Milad, Orr, Pitman, & Rauch, 2005). Each fear extinction phase consisted of 
five CS+ presentations, and five CS- presentations, with no US-delivery on any trial. 
Reinstatement occurred immediately following extinction training, with two unsignalled 
presentations of the US (during passive viewing of the blank computer screen), followed by a 
return of fear test, with five presentations of each of the CS-types. All experimental phases 
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were conducted in a single context, and at the end of testing, participants were asked which 
coloured circle was associated with the mild electric shock, to which all participants reported 
accurate contingency awareness.  
 
Skin conductance response. As with previous research from our lab, skin conductance 
level was measured through a 22 mVrms, 75Hz constant-voltage coupler (FE116, ADI 
Instruments) with bipolar electrodes on the intermediate phalange of the first and third fingers 
of the non-dominant hand, sampled at 512Hz and stored at 64Hz, and recorded in micro-
Siemens (μS). Participants were instructed to keep their hand as still as possible for the 
duration of the task, so as to reduce the potential for movement artefact. Skin conductance 
response (SCR) amplitude was calculated by subtracting the mean SCL in the 2s prior to CS 
onset from the maximum SCL during CS presentation (i.e., max SCL during CS – mean SCL 
in 2s prior to CS onset; Milad et al., 2013; Milad et al., 2008; Milad et al., 2005). Prior to 
statistical analyses, all SCR values were square-root transformed. The absolute value of 
negative SCR levels was transformed, and the negative sign replaced. For use in moderation 
analyses, a fear return index was calculated by subtracting the mean SCR amplitude of trials 
4 and 5 of late extinction from the first trial of the return of fear phase. This index was 
calculated separately for each CS-type, with larger values indicating a greater return of fear. 
 
US-expectancy ratings. During each presentation of the CS, participants were asked to 
provide a threat expectancy rating that the current CS would be followed by the aversive US. 
Ratings were made via a mouse-click on a scale from 0 (“certain no electrical stimulus”) to 
100 (“certain electrical stimulus”), presented below the CS. 
 
2.4. Statistical analyses 
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Demographic and clinical data were conducted using one-way analyses of variance 
(ANOVAs), and Welch adjusted F-ratios were reported where Levene’s test of homogeneity 
of variance was violated. Follow-up comparisons were conducted using Bonferroni 
corrections, or Games-Howell analyses where appropriate. The habituation, acquisition, and 
extinction phases were analyzed with separate 2 (CS) × 5 (trial) × 3 (group) mixed ANOVAs 
(with 4 levels of trial for the habituation phase). The US-expectancy data from three 
participants was missing and thus were not included in US-expectancy analyses. Excluding 
these three participants from other analyses showed little difference to significance and effect 
sizes, and thus these participants were retained in all other analyses. Reinstatement effects 
were assessed using a 2 (time) × 2 (CS) × 3 (group) mixed ANOVA. Time was quantified as 
the SCR amplitude on the first trial of the return of fear phase subtracted from the average 
SCR amplitude on trials 4 and 5 of late extinction (Haaker et al., 2014; Kindt, Soeter, & 
Vervliet, 2009; Soeter & Kindt, 2010). Greenhouse-Geisser corrected degrees of freedom and 
epsilon values are reported for all repeated measures ANOVAs. Effect sizes are reported as 
partial eta-squared (ηp
2) for ANOVAs, and Cohen’s d for pairwise comparisons, according to 
the criteria of 0.2, 0.5, and 0.8 as small, medium, and large effects, respectively (Cohen, 
1988).  
Moderation analyses were conducted using the PROCESS macro v3.0 for SPSS 
(Hayes, 2013). Moderation is a regression-based technique and all moderators and predictors 
were visually inspected for homoscedasticity of residuals. Moderation analyses were 
conducted individually for the PSQI total score and six subscales (the medications subscale 
was included as a covariate, alongside age), separately for the CS+ and CS-. Further, 
moderation analyses were repeated for reinstatement variables derived from SCR amplitude 
and US-expectancy ratings. To protect against the likelihood of Type I errors, a False 
Discovery Rate correction was applied to the subsequent 28 interaction terms at the value of 
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q = 0.05, according to the Benjamini-Hochberg correction method (Benjamini & Hochberg, 




As shown in Table 1, one-way ANOVA revealed no significant between-group 
differences on age, F(2, 41.56) = 2.56, p = .089. As expected, there were significant between-
group differences on the PCL-C total score, F(2, 37.29) = 70.38, p < .001, with the PTSD 
group displaying significantly greater symptom severity than the TC and NTC groups (ps < 
.001), who also significantly differed (p = .001). The ANOVA revealed a significant 
between-group difference on total scores for the PSQI, F(2, 39.76) = 9.76, p < .001, with the 
PTSD group reporting significantly poorer sleep quality than the TC and NTC groups (p = 
.010 and p = .001, respectively), who did not significantly differ (p = .199). See Table 1 for 
the descriptive and inferential statistics for the PSQI subscales. There were no significant 
between-group differences on the Alcohol Use Disorder Identification Test (AUDIT), F(2, 
71) = 1.15, p = .970. 
 
[INSERT TABLE 1 ABOUT HERE] 
 
3.2. US-expectancy Ratings 
Habituation. There was a significant main effect of trial during habituation, with US-
expectancy ratings declining across the phase, irrespective of CS-type or group, F(2.03, 
137.68) = 6.79, p = .001, ηp
2 = .091, ε = .675.  
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Acquisition. During acquisition there were significant main effects of CS-type, F(1, 
68) = 288.56, p < .001, d = 3.65, and trial, F(3.27, 222.18) = 5.23, p = .001, ηp
2 = .071, ε = 
.817. These main effects were superseded by a significant CS × trial interaction, F(3.37, 
229.45) = 109.78, p < .001, ηp
2 = .618, ε = .844. This interaction shows clear differential US-
expectancy between the CS+ and CS- developing over the acquisition phase (see Fig. 1). 
There was no significant main effect of group (p = .630), or interaction involving group (ps > 
.098). 
 
Early extinction. As with acquisition, the early extinction phase showed significant 
main effects of CS, F(1, 68) = 55.00, p < .001, d = 1.09, and trial, F(2.50, 169.64) = 73.02, p 
< .001, ηp
2 = .518, ε = .624. Similarly, there was also a significant CS × trial interaction, 
F(3.40, 231.15) = 10.63, p < .001, ηp
2 = .091, ε = .850, with differential expectancy ratings to 
the CS+/- reducing over early extinction (see Fig. 1), with no main effects or interactions 
involving group (ps > .200). 
 
Late extinction. The late extinction phase also showed significant main effects of CS, 
F(1, 68) = 20.70, p < .001, d = 0.44, and trial, F(2.19, 148.68) = 39.57, p < .001, ηp
2 = .368, ε 
= .547. Again, these main effects were superseded by a significant CS × trial interaction, F(4, 
272) = 3.89, p = .004, ηp
2 = .054. All groups showed further reductions in CS+/- 
discrimination across trials (see Fig. 1). There was also a significant group main effect, F(2, 
68) = 3.67, p = .031, ηp
2 = .097, with the PTSD group reporting greater threat uncertainty (M 
= 37.90 [27.97, 47.82], SD = 21.68), relative to the TC and NTC groups (M = 22.69 [14.66, 
30.72], SD = 21.68, and M = 22.07 [16.85, 27.30], SD = 21.68, respectively), who showed 
little difference. Threat uncertainty refers to scores closer to 50 – representing the middle-
point of the US-expectancy scale – as opposed to greater reported confidence in the US being 
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absent or present, as indicated by expectancy ratings closer to 0 or 100, respectively. 
Between-group differences were no longer significant following a Bonferroni correction for 
multiple comparisons (ps > .053). 
 
Reinstatement. ANOVA revealed a significant increase in US-expectancy ratings 
from the final two trials of late extinction (M = 29.71, 95% CI[20.54, 38.89], SD = 38.76) to 
the first trial post-reinstatement (M = 48.28 [42.95, 53.61], SD = 22.50), F(1, 68) = 16.70, p < 
.001, d = 0.59. There was also a significant main effect of CS-type, F(1, 68) = 11.93, p = 
.001, d = 0.40, with greater US-expectancy of the CS+ (M = 44.83 [37.44, 52.23], SD = 
31.26) compared to the CS- (M = 33.16 [26.87, 39.45], SD = 26.54). There was, however, no 
significant time × CS interaction (p = .631) suggesting a generalized reinstatement of threat 
expectancy. ANOVA also revealed a significant main effect of group, F(2, 68) = 4.38, p = 
.016, ηp
2 = .114, with the PTSD group displaying significantly elevated threat expectancy (M 
= 52.04 [40.65, 63.43], SD = 24.87) compared to the TC group (M = 31.64 [22.42, 40.86], SD 
= 24.87; p = .021), and borderline significant threat expectancy compared to the NTC (M = 
33.32 [22.97, 43.66], SD = 24.87; p = .053), averaged across time. The TC and NTC groups 
did not differ (p = .993). This effect indicates that – compared to the TC and NTC groups – 
the PTSD group displayed elevated uncertainty of the US over the end of the late extinction 
phase and beginning of the reinstatement (return of fear) phase, however there were no 
significant between-group increases from late extinction to return of fear test. 
 
[INSERT FIGURE 1 ABOUT HERE] 
 
3.3. SCR Amplitude 
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Habituation. ANOVA revealed a significant main effect of trial during the habituation 
phase, F(2.77, 196.48) = 2.94, p = .038, ηp
2 = .040, ε = .922, with SCR amplitude decreasing 
across trials, irrespective of group or CS-type. No further main effects or interactions were 
significant (all ps > .306). 
 
Acquisition. During acquisition, SCR amplitude was significantly larger to the CS+ 
(M = 0.88 [0.76, 1.00], SD = 0.52) compared to the CS- (M = 0.42 [0.32, 0.53], SD = 0.46), 
F(1, 71) = 82.03, p < .001, d = 0.94. Further, there was a borderline significant group × CS 
interaction, F(2, 71) = 2.73, p = .072, ηp
2 = .071, which appears to be driven largely by a 
greater average differential conditioned response in the NTC group. ANOVA also showed a 
significant main effect of trial, with a significant overall reduction of SCR amplitude across 
the experimental phase (see Fig. 2), irrespective of group or CS-type, F(3.54, 251.23) = 
12.46, p < .001, ηp
2 = .149, ε = .885. No further main effects or interactions were significant 
(all ps > .328). 
 
Early extinction. Overall, participants were still displaying significantly larger SCR 
amplitude responses to the CS+ (M = 0.58 [0.49, 0.67], SD = 0.40), compared to the CS- (M 
= 0.42 [0.34, 0.50], SD = 0.34) during the early extinction phase, F(1, 71) = 17.13, p < .001, 
d = 0.43. Further, there was a significant main effect of trial, F(3.49, 248.06) = 29.37, p < 
.001, ηp
2 = .293, ε = .873, with SCR amplitude decreasing across the early extinction phase, 
irrespective of group or CS-type. No further main effects or interactions were significant (all 
ps > .174). 
 
Late extinction. Irrespective of group, participants were still displaying significantly 
larger SCR amplitude responses to the CS+ (M = 0.47 [0.37, 0.58], SD = 0.46) than the CS- 
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(M = 0.39 [0.30, 0.47], SD = 0.37), F(1, 71) = 4.19, p = .044, d = 0.20. ANOVA also showed 
a significant main effect of trial, F(3.32, 235.50) = 16.70, p < .001, ηp
2 = .190, ε = .829, with 
SCR amplitudes further decreasing across trials, irrespective of group or CS-type. No further 
main effects or interactions were significant during late extinction (all ps > .276). 
 
Reinstatement. As shown in Fig. 2, there was an increase in SCR amplitude from the 
end of late extinction, to immediately post-reinstatement, however there was no significant 
time × CS interaction, F(1, 71) = 2.54, p = .116, ηp
2 = .034, or effect involving group, 
indicating that all groups displayed a generalized reinstatement of fear to both the CS+ and 
CS-. There was a significant main effect of CS-type, with larger overall SCR amplitude to the 
CS+ (M = 0.60 [0.45, 0.76], SD = 0.67) than the CS- (M = 0.42 [0.29, 0.55], SD = 0.56), F(1, 
71) = 6.70, p = .012, d = 0.30. No further main effects or interactions were significant (all ps 
> .116). 
 
[INSERT FIGURE 2 ABOUT HERE] 
 
3.4. Moderation 
Moderation analyses were conducted using the PROCESS macro v3.0 for SPSS 
(Model 1; Hayes, 2013). PCL-C total was entered into the model as the outcome variable, 
and reinstatement of fear was calculated as the average response to trials 4 and 5 of late 
extinction, subtracted from the first trial of reinstatement. Analyses were conducted 
individually for the PSQI total score and six subscales (with the exception of the medications 
subscale). Analyses were further repeated for the CS+ and CS- and for the SCR and US-
expectancy ratings. 
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Following a false discovery rate correction according to the Benjamini-Hochberg 
correction method for multiple comparisons (Benjamini & Hochberg, 1995), sleep 
disturbance was a significant moderator between fear return to the CS+ and PTSD symptom 
severity, such that there was a positive relationship between PTSD symptoms and fear 
reinstatement for high levels of sleep disturbance, but not for lower levels of sleep 
disturbance (see Fig. 3a), R2 = .278, F(3, 70) = 8.96, p < .001. For longer sleep onset latency, 
there was a positive relationship between PTSD symptoms and fear reinstatement. In 
contrast, for shorter sleep onset latency, there was a negative relationship between PTSD 
symptoms and fear reinstatement (see Fig. 3b), R2 = .210, F(3, 70) = 6.21, p < .001. Analyses 
were repeated with age and PSQI medications subscale as covariates, resulting in the sleep 
onset latency moderation no longer found to be significant after a false discovery rate 
correction.  
To further clarify the moderating role of sleep disturbance and sleep onset latency on 
PCL-C scores, we repeated analyses with each symptom cluster of the PCL-C for DSM-IV 
(i.e., intrusive memories, avoidance behaviours, and hyperarousal) as the outcome variable. 
Effects remained unchanged for each symptom cluster, suggesting a general effect of PTSD 
symptomatology (see Supplementary Materials). 
 
[INSERT FIGURE 3 ABOUT HERE] 
 
[INSERT TABLE 2 ABOUT HERE] 
 
4. Discussion 
We used a within-session differential fear conditioning, extinction and reinstatement 
paradigm to investigate sleep quality as a moderator of fear reinstatement in PTSD, compared 
 17 
to trauma-exposed and non-exposed controls. Our findings show that increased fear 
expression to the CS+ after reinstatement was associated with greater PTSD symptom 
severity, and this relationship became stronger with greater – but not lower – levels of 
subjective sleep disturbance. A similar pattern was also found with increased sleep onset 
latency. Fear reinstatement was not associated with other subscales of the PSQI, and was not 
associated with PTSD symptoms independently, suggesting that sleep disturbance (and sleep 
onset latency) may be important boundary conditions of fear reinstatement. To our 
knowledge, this is the first investigation of the role of sleep in fear reinstatement, and also the 
first investigation of the PTSD-specific effects of fear reinstatement. 
 The boundary conditions of fear reinstatement are currently not well understood (with 
the exception of context; Haaker et al., 2014), and the findings of the current study suggest 
that sleep disturbance and sleep onset latency play an important role in PTSD-related fear 
reinstatement. Previous research has shown that sleep disturbances in PTSD are improved 
with exposure-based therapies (Gutner, Casement, Stavitsky Gilbert, & Resick, 2013; Long et 
al., 2011; although see Sexton et al., 2017), but also that imagery rehearsal therapy for 
nightmares lead to reductions in PTSD symptoms (Krakow et al., 2001). Exposure therapy is 
also strengthened in spider phobic patients if therapy is followed by a 90-minute nap, rather 
than wakefulness (Kleim et al., 2014). The results of the current study support these previous 
findings, suggesting that sleep quality plays an important mechanistic role in the 
consolidation of fear extinction memories. 
 The current study also found sleep onset latency to be a significant moderator 
between fear reinstatement and PTSD. It is important to note that after including age and 
sleep medication use as covariates, a false discovery rate correction resulted in this effect 
being deemed non-significant, and therefore the following explanations should be interpreted 
with caution. Previous research shows that adults with chronic PTSD report a number of 
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severe sleep disturbances, with longer sleep onset latency significantly associated with daily 
stressors (Gehrman, Harb, Cook, Barilla, & Ross, 2015). Further, increased sleep onset 
latency is significantly associated with anxiety sensitivity in anxious children (Weiner, 
Meredith Elkins, Pincus, & Comer, 2015) and adults (Babson, Trainor, Bunaciu, & Feldner, 
2008). Previous research by Spoormaker et al. (2014) found that increased ventromedial 
prefrontal cortex (vmPFC) activity during fear conditioning is associated with greater sleep 
latency that night. Alternatively, vmPFC hypoactivity has been associated with poor 
consolidation of extinction memories over a 24-h period in PTSD (Milad et al., 2009). Nota 
and Coles (2018) recently demonstrated that longer sleep onset latency is associated with 
poor attentional disengagement from negative emotional stimuli in individuals who display 
repetitive negative thinking styles. Based on the aforementioned research, we speculate that 
longer sleep onset latency is associated with heightened physiological and emotional arousal 
immediately prior to sleep (Gehrman et al., 2015), which may reduce emotional capacity to 
accurately form extinction memories. As such, poorly consolidated extinction is likely to be 
particularly susceptible to fear reinstatement, with some involvement of vmPFC hypoactivity. 
As noted above, this explanation is speculative, but plausible, and further research is needed 
to investigate this explanation. Furthermore, we also found that shorter sleep latency showed 
a negative relationship between PTSD symptoms and reinstatement, such that greater return 
of fear was associated with lower PTSD symptoms. This effect was unexpected, and we are 
unsure of underlying mechanisms here. 
The hippocampus also plays an important role in the above vmPFC-amygdala 
network in the consolidation of emotional fear memories. In particular, the hippocampus is 
involved in changes to contingency awareness (Lang et al., 2009; Milad et al., 2007), such as 
those brought on by contextual shifts or changes in the CS-US relationship. Reinstatement 
paradigms typically result in greater prediction error of the CS+ to accurately predict the US. 
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In addition, there is recent evidence that sleep deprivation prevents the inhibition of 
amygdala activity by the vmPFC during fear consolidation (Feng, Becker, Zheng, & Feng, 
2018). With the amygdala-hippocampus-mPFC network showing greatest activation during 
REM sleep (Genzel, Spoormaker, Konrad, & Dresler, 2015), this cortical network could 
speculatively play an important role in fear reinstatement via cortical activity during REM 
sleep.  
 In the current study, sleep quality was measured retrospectively via the self-report 
Pittsburgh Sleep Quality Index (Buysse et al., 1989). While this scale is widely used and 
demonstrates strong psychometric properties (Mollayeva et al., 2016), the use of a sleep diary 
for a longitudinal assessment of sleep quality in the lead up to participation, and objective 
measures of sleep quality/behaviour (e.g., via actigraph or polysomnography) may shed light 
on the specific sleep mechanisms between fear reinstatement and PTSD symptoms. For 
example, recent research has shown important contributions of REM sleep amount in the 
extinction of fear (Spoormaker et al., 2014) and there is growing evidence for a role of slow-
wave sleep architecture in emotional memory consolidation (Diekelmann & Born, 2010), 
with complementary processes between slow-wave and REM sleep (Cairney, Durrant, Power, 
& Lewis, 2015). Further, while participants reported abstinence from caffeine on the day of 
testing, future research would benefit from employing additional sleep hygiene steps in the 
days prior to testing.  
Future research should also include a control group that does not receive the 
reinstatement stimuli, as this allows for stronger conclusions that return of fear effects are 
attributed to the unsignalled US presentations, rather than the passage of time from extinction 
learning to return of fear test (spontaneous recovery). Although this is unlikely to be an issue 
in the current study as reinstatement occurs immediately following extinction (Haaker et al., 
2014). The use of a 100% US-reinforcement schedule during acquisition is known to result in 
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rapid extinction learning, and a partial reinforcement schedule may be more appropriate to 
increase the uncertainty and strength of conditioned responses. For example, Grady, Bowen, 
Hyde, Totsch, and Knight (2016) found that a partial reinforcement schedule during early 
acquisition, followed by 100% reinforcement for the remainder of the acquisition phase 
resulted in a stronger conditioning trace, and more persistent conditioned responses during 
extinction, relative to fully continuous or partial reinforcement schedules alone. Further, we 
had a mixed trauma sample, with single incident, cumulative incident, and multiple trauma 
types. Future research might benefit from control of trauma type, or examining the effect of 
trauma type or cumulative trauma on the propensity for fear reinstatement. 
 
5. Conclusions 
Here we show that sleep disturbance (and sleep onset latency) significantly moderate 
the relationship between reinstatement and PTSD symptoms. Specifically, the relationship 
between greater fear reinstatement and increased PTSD symptoms becomes stronger with 
greater sleep disturbances and longer sleep latency onset. Further, to our knowledge this is 
the first study examining fear reinstatement in a clinical sample with PTSD, and suggests that 
reinstatement effects do not present in isolation in PTSD, but rather interact with additional 
factors (such as sleep disturbance). As such, these findings imply that sleep disturbances and 
longer sleep onset latency may weaken fear extinction consolidation, resulting in a weaker 
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Descriptive and between-group data for demographic and clinical measures 
PTSD, Posttraumatic Stress Disorder; TC, Trauma-exposed controls; NTC, Non-trauma-exposed controls; PCL-C, PTSD Checklist-Civilian 
version; DASS, Depression Anxiety Stress Scale; PSQI, Pittsburgh Sleep Quality Index; AUDIT, Alcohol Use Disorder Identification Test. 
 PTSD (n = 20) TC (n = 29) NTC (n = 25)   
 M [95% CI], SD M [95% CI], SD M [95% CI], SD Test statistic p 
Demographic data      
Age (years) 33.3 [26.4, 40.1], 14.7 26.5 [22.7, 30.3], 9.9 24.5 [20.4, 28.6], 10.0 F(2, 41.56) = 2.56a .089 
Sex 9M, 11F 15M, 14F 7M, 18F χ2(2) = 3.21 .201 
PCL-C      
Total 51.1 [45.6, 56.5], 11.7 23.4 [21.9, 24.9], 3.9 20.0 [18.9, 21.0], 2.6 F(2, 37.29) = 70.38a < .001 
Intrusive 2.9 [2.3, 3.5], 1.3 0.2 [0.1, 0.4], 0.4 - F(2, 71) = 114.05 < .001 
Avoidance 4.1 [3.2, 5.0], 1.9 0.4 [0.2, 0.7], 0.7 0.2 [0.0, 0.4], 0.5 F(2, 37.81) = 38.62a < .001 
Hyperarousal 3.3 [2.8, 3.8], 1.1 0.4 [0.2, 0.7], 0.7 0.2 [0.0, 0.4], 0.5 F(2, 39.53) = 66.96a < .001 
DASS      
Depression 8.8 [6.2, 11.4], 5.5 2.2 [1.3, 3.1], 2.5 1.3 [0.6, 2.1], 1.8 F(2, 38.50) = 16.67a < .001 
Anxiety 7.9 [5.8, 9.9], 4.4 2.0 [1.3, 2.8], 2.0 1.0 [0.4, 1.7], 1.6 F(2, 39.03) = 21.75a < .001 
Stress 12.8 [9.7, 15.8], 6.5 5.0 [3.8, 6.2], 3.2 2.4 [1.4, 3.3], 2.3 F(2, 38.80) = 25.66a < .001 
PSQI      
Total 8.0 [6.3, 9.7], 3.7 5.0 [4.1, 5.9], 2.4 4.1 [3.4, 4.8], 1.6 F(2, 39.76) = 9.76a < .001 
Disturbance 1.7 [1.4, 2.0], 0.6 1.4 [1.2, 1.6], 0.6 1.2 [1.0, 1.4], 0.4 F(2, 43.37) = 5.39a .008 
Duration 0.6 [0.2, 0.9], 0.8 0.2 [0.1, 0.4], 0.4 0.1 [0.0, 0.2], 0.3 F(2, 38.51) = 3.36a .045 
Day dysfunction 1.5 [1.1, 1.8], 0.7 0.9 [0.7, 1.1], 0.5 0.9 [0.6, 1.2], 0.7 F(2, 71) = 2.45 .004 
Efficiency 0.8 [0.3, 1.3], 1.1 0.2 [0.0, 0.5], 0.5 0.2 [0.0, 0.3], 0.4 F(2, 38.92) = 3.29a .048 
Latency 1.6 [1.0, 2.1], 1.2 1.3 [1.0, 1.7], 0.9 1.0 [0.7, 1.2], 0.7 F(2, 41.38) = 2.78a .074 
Medications 0.6 [0.0, 1.1], 1.1 0.1 [-0.1, 0.2], 0.4 0.1 [0.0, 0.4], 0.7 F(2, 37.88) = 1.65a .207 
Sleep quality 1.4 [1.1, 1.7], 0.7 1.0 [0.7, 1.3], 0.8 0.7 [0.5, 0.9], 0.5 F(2, 71) = 2.57 .004 
AUDIT 6.2 [3.7, 8.7], 5.3 5.9 [4.5, 7.3], 3.8 6.1 [4.3, 7.8], 4.2 F(2, 71) = 0.57 .970 
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aWelch adjusted F-ratio. 
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Table 2  
Moderation analyses examining the relationship between reinstatement of fear to the CS+ and 
PCL-C total, moderated by PSQI subscales (sleep disturbances and sleep latency) 
Analyses b[95% CI] SEb t p 
PSQI sleep disturbance  
Constant 
ROF to the CS+ 
PSQI disturbance 
ROF × disturbance 
 
20.25 [11.13, 29.36] 
-15.48 [-26.65, -4.31] 
6.17 [-0.04, 12.39] 
















PSQI sleep onset latency 
Constant 
ROF to the CS+ 
PSQI latency 
ROF × latency 
 
28.60 [22.95, 34.26] 
-9.26 [-16.08, -2.44] 
-0.84 [-5.18, 3.50] 
















PSQI, Pittsburgh Sleep Quality Index; ROF, return of fear; SE, standard error. 
aSignificant following the inclusion of age and PSQI medications as covariates, and a further 
false discovery rate correction.  
bRemains significant following the inclusion of age and PSQI medications as covariates, but 
is deemed non-significant by the subsequent false discovery rate correction. 
 
